These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35219108)

  • 21. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity.
    Lacroix PM; Dawson BA; Sears RW; Black DB; Cyr TD; Ethier JC
    J Pharm Biomed Anal; 1998 Nov; 18(3):383-402. PubMed ID: 10096833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Structural Elucidation of New Process Impurity in Testosterone.
    Gupte V; Luthra U; Desai N
    J Chromatogr Sci; 2018 May; 56(5):403-408. PubMed ID: 29554236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Identification of the impurities in
    Ma X; Jin L; Li Y; Zheng H; Wei Y
    Se Pu; 2018 Mar; 36(3):268-277. PubMed ID: 30136505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Isolated Method and Assignment for Critical Impurities in Semi-Synthetic Process of Arbekacin Sulfate.
    Chen ZH; Zhou H; Wang S; Li G; Zhang J; Wang F; Li C; Qiao RZ
    Pharmazie; 2019 Jun; 74(6):352-356. PubMed ID: 31138373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impurity profiling of L-methionine by HPLC on a mixed mode column.
    Kühnreich R; Holzgrabe U
    J Pharm Biomed Anal; 2016 Apr; 122():118-25. PubMed ID: 26852161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid Purification and Formulation of Radiopharmaceuticals via Thin-Layer Chromatography.
    Laferriere-Holloway TS; Rios A; Carlucci G; van Dam RM
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and identification of four major impurities in capreomycin sulfate.
    Liu G; Luan B; Liang G; Xing L; Huang L; Wang C; Xu Y
    J Chromatogr A; 2018 Oct; 1571():155-164. PubMed ID: 30115387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.
    Cao X; Tai Y; Sun C; Wang K; Pan Y
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):39-45. PubMed ID: 16085133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semi-preparative LC-SPE-cryoflow NMR for impurity identifications: use of mother liquor as a better source of impurities.
    Rinaldi F; Fan J; Pathirana C; Palaniswamy V
    Magn Reson Chem; 2013 Sep; 51(9):517-22. PubMed ID: 23788325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization and troubleshooting of preparative liquid chromatography using statistical design of experiments: Four small-molecule case studies.
    Hochdorfer TS; Wang K
    J Chromatogr A; 2022 Aug; 1676():463212. PubMed ID: 35716463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.
    Satyanarayana U; Rao DS; Kumar YR; Babu JM; Kumar PR; Reddy JT
    J Pharm Biomed Anal; 2004 Jun; 35(4):951-7. PubMed ID: 15193741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
    Zhou H; Tai Y; Sun C; Pan Y
    J Pharm Biomed Anal; 2005 Feb; 37(1):97-107. PubMed ID: 15664748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
    Chen ZZ; Zhang DS; Wang N; Feng F; Hu CQ
    Yao Xue Xue Bao; 2012 Apr; 47(4):492-7. PubMed ID: 22799032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality by design with design of experiments approach for development of a stability-indicating LC method for enzalutamide and its impurities in soft gel dosage formulation.
    Katakam LNR; Dongala T; Ettaboina SK
    Biomed Chromatogr; 2021 May; 35(5):e5062. PubMed ID: 33410554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-technique approach using LC-NMR, LC-MS, semi-preparative HPLC, HR-NMR and HR-MS for the isolation and characterization of low-level unknown impurities in GW876008, a novel corticotropin-release factor 1 antagonist.
    Provera S; Rovatti L; Turco L; Mozzo S; Spezzaferri A; Bacchi S; Ribecai A; Guelfi S; Mingardi A; Marchioro C; Papini D
    J Pharm Biomed Anal; 2010 Nov; 53(3):517-25. PubMed ID: 20619567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.